Which of the following is stated correctly using metric abbreviations and rules?
Ampicillin 500 mg
ampicillin mg 500
ampicillin 500 MG
ampicillin 500.0 mg
The Correct Answer is A
A) Ampicillin 500 mg
This is correctly written using metric abbreviations and follows standard rules for medication dosage. In the metric system, the drug name is followed by the dose, with the unit of measurement ("mg" for milligrams) written in lowercase. The correct usage of the unit abbreviation "mg" and proper spacing between the medication and the dose makes this option correct. Additionally, no trailing zeros are used, which is important for avoiding confusion in clinical settings.
B) ampicillin mg 500
This is incorrect because the unit of measurement ("mg") should follow the dose, not precede it. The correct format places the drug name first, followed by the numerical dose, and then the unit of measurement (in this case, "mg"). The unit abbreviation should be lowercase and placed after the dose. This structure is standard in pharmaceutical and medical documentation.
C) ampicillin 500 MG
While this provides the correct drug name and dosage, the unit abbreviation "MG" is written in uppercase, which is incorrect according to standard guidelines. Unit abbreviations should be written in lowercase letters unless they are the first word in a sentence. Writing "MG" in uppercase can lead to confusion and does not follow the convention for unit symbols.
D) ampicillin 500.0 mg
This is also incorrect because of the unnecessary trailing zero after the decimal point. In medication dosage, a trailing zero (e.g., 500.0 mg) is considered a potential error, as it can be misinterpreted. For example, a dosage of "500.0 mg" may be misread as a higher dose (e.g., 500 mg vs. 500.0 mg), and this could lead to medication errors. Standard practice is to avoid using trailing zeros unless they are required to prevent ambiguity (e.g., 0.5 mg).
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A) Nausea
Nausea is not the most common or primary complication associated with thrombolytic drugs. While some patients may experience nausea as a minor side effect, it is not the hallmark complication of thrombolytic therapy. Thrombolytic drugs are used to dissolve blood clots, and their primary concern is related to bleeding due to their potent effect on clotting factors.
B) Hypertension
Hypertension (high blood pressure) is not typically associated with thrombolytic therapy. In fact, thrombolytic drugs are more likely to cause hypotension (low blood pressure) in some cases, especially if bleeding complications lead to significant blood loss.
C) Fever
Fever can occur as a side effect of many medications or conditions, but it is not a common or direct complication of thrombolytic therapy. Fever may occasionally arise as a response to infection, inflammation, or even the breakdown of clots, but it is not a primary concern when using thrombolytic drugs.
D) Bleeding
Bleeding is the most common and serious complication associated with thrombolytic drugs. These medications work by breaking down fibrin, the protein responsible for clot formation, to dissolve blood clots. While this is beneficial in conditions like myocardial infarction, stroke, or pulmonary embolism, it increases the risk of bleeding throughout the body. Bleeding can occur at various sites, including internal bleeding, gastrointestinal bleeding, and bleeding at the injection site.
Correct Answer is ["A","B","D","E"]
Explanation
A) Subcutaneous:
The subcutaneous route involves administering medication into the layer of fat and connective tissue beneath the skin. This method is used for drugs that require slower absorption, such as insulin or certain vaccines.
B) Intramuscular:
The intramuscular route involves injecting medication directly into a muscle. This allows for faster absorption compared to subcutaneous injections, making it ideal for drugs that need to be absorbed quickly, such as vaccines or certain antibiotics.
C) Via a nasogastric tube:
Administering drugs via a nasogastric tube is not considered a parenteral route. The nasogastric (NG) tube delivers medications directly into the stomach via the gastrointestinal tract, which is not part of the parenteral system. Parenteral routes are those that bypass the digestive system, like injections.
D) Intradermal:
The intradermal route involves injecting medication just under the skin, in the dermis. This is typically used for allergy testing or tuberculosis screenings. It is a parenteral route because it bypasses the digestive system.
E) Intravenous:
The intravenous route involves injecting medication directly into a vein, offering rapid absorption and fast onset of action. This method is ideal for critical or emergency situations where immediate medication effects are necessary.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.